XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Taxes  
Schedule of income (loss) before income taxes

Year Ended

December 31, 

    

2021

    

2020

U.S.

$

(39,155)

$

(28,699)

Foreign

 

(1,456)

 

1,183

Loss before income taxes

$

(40,611)

$

(27,516)

Schedule of Company's current and deferred expense for income tax

Year Ended

December 31, 

    

2021

    

2020

Current expense (benefit):

Federal

$

$

State

 

 

Foreign

 

(37)

 

40

Total current expense (benefit):

$

(37)

$

40

Deferred expense (benefit):

Federal

$

$

State

 

 

Foreign

 

13

(42)

Total deferred expense (benefit):

$

13

$

(42)

Total income tax expense (benefit):

$

(24)

$

(2)

Schedule of reconciliation of the Company's statutory income tax rate to the Company's effective income tax rate

Year Ended

 

December 31, 

    

2021

    

2020

 

Income at US Statutory Rate

 

21.0

%  

21.0

%

State Taxes, net of Federal benefit

 

7.2

%  

7.0

%

Permanent Differences

 

(1.8)

%  

(1.1)

%

Tax Credits

 

3.9

%  

6.0

%

Foreign Rate Differential

 

0.2

%  

(0.5)

%

Israel DTA write-off

0.0

%  

(70.2)

%  

Valuation Allowance

 

(30.6)

%  

36.6

%

Other

 

0.1

%  

1.2

%

 

0.0

%  

0.0

%

Schedule of significant components of the Company's deferred tax assets

Year Ended

December 31, 

    

2021

    

2020

Accrued expenses

$

729

$

455

License Fees

1,004

 

1,168

Stock Options

4,671

 

3,759

Other

212

 

228

State net operating loss carryforwards

11,246

 

8,959

State research tax credits

1,006

 

625

Federal net operating loss carryforwards

41,207

 

33,711

Federal research tax credits

6,166

 

4,943

Total deferred tax assets

66,241

53,848

Valuation allowance

 

(66,082)

 

(53,669)

Net deferred tax asset (liability)

$

159

$

179